PJ, July 2022, Vol 309, No 7963

RPS appoints new member experience and education lead

Neville Carter will join the Royal Pharmaceutical Society as chief education and membership officer in October 2022.…

NHS receives £10m to develop national drone medicine delivery service in Scotland

Drone landing stations have already been designed for NHS sites across Scotland, with a vision to connect hospitals, laboratories, GP surgeries and distribution centres.…

Chief pharmaceutical officer opens outreach health hub in Hindu temple

The 'Health Hub' at Neasden Temple has been set up to provide health advice, information and free screening to the local community.…

Pharmacy foundation training: how has the first year gone?

Pharmacy trainers and the first ever cohort of foundation pharmacy trainees share their experiences and what they would like to see improved.…

Updated NICE guidance for type 2 diabetes: what do you need to know?

In this episode of the PJ Pod, we explore the main changes and implications for practice brought about by the National Institute for Health and Care Excellence update to the ‘Type 2 diabetes in adults: management’ guideline.…

NHS staff with ‘disabling conditions’ after COVID-19 should be able to claim benefits, say government advisers

Exclusive: By listing health complications from COVID-19 as part of the Industrial Injuries Disablement Benefit scheme, people affected by the virus would qualify for up to £188.60 in weekly benefits.…

Safety review launched into anti-epileptic medicine topiramate over fears of harm to unborn children

The review was prompted by study results that showed there was a two- to four-fold increased risk of developmental disorders or learning difficulties in children exposed to topiramate before birth.…

Discontinuation of antidepressant could affect tapering patients, say experts

Exclusive: Paroxetine 20mg/10mL oral suspension is being discontinued, but experts have highlighted how these liquid formulations of antidepressants are "essential" for successfully tapering patients.…

Edoxaban switching scheme: worth the risks?

GP practices in England are being paid millions of pounds to switch up to a third of patients to edoxaban, currently the cheapest choice of anticoagulant for the NHS. However, switching is not always straightforward and there is speculation that patients will need to be switched again in the future.…

Pharmacy negotiator tells government it is ‘increasingly concerned’ over medicines supply

The Pharmaceutical Services Negotiating Committee said that many pharmacies were in a "critical situation" trying to source medicines in a timely manner.…